Back

Heart generation via blastocyst complementation in Mesp1/2-deficient mice

Abe, Y.; Sadahiro, T.; Fujita, R.; Yamada, Y.; Akiyama, T.; Nakano, K.; Honda, S.; Tanimoto, Y.; Suzuki, H.; Mizuno, S.; Takahashi, S.; Yamaguchi, T.; Masaki, H.; Hattori, K.; Mashimo, T.; Ieda, M.

2023-11-08 cell biology
10.1101/2023.11.08.565924 bioRxiv
Show abstract

Heart transplantation is the only curative option available for patients with advanced heart failure. However, donor organ shortage and graft rejection remain critical challenges in heart transplantation. Blastocyst complementation using pluripotent stem cells (PSCs) can be used to generate organs such as the pancreas and kidneys in animal models with abnormalities in essential developmental genes. Nonetheless, whether functional adult hearts can be generated with blastocyst complementation remains unclear, and it is unknown if parenchyma, blood vessels, and stroma can be generated concomitantly from PSCs using blastocyst complementation to avoid graft rejection. Here, we show the generation of functional adult hearts in acardiac Mesp1 and Mesp2 double-knockout (Mesp1/2-DKO) mice via blastocyst complementation using mouse PSCs. Our result shows that the generated hearts were structurally and functionally normal and restored embryonic lethality in Mesp1/2-DKO mice. All four cardiovascular lineages, including cardiomyocytes, vascular endothelial cells, smooth muscle cells, and cardiac fibroblasts, were virtually entirely derived from exogenous PSCs in the myocardium. Exogenous rat PSCs also generated rat-derived xenogeneic hearts in Mesp1/2-DKO mice via interspecies blastocyst complementation. Thus, blastocyst complementation is a viable technique for generating hearts derived from PSCs and may represent significant progress toward generating rejection-free hearts.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 0.2%
14.4%
2
PLOS ONE
4510 papers in training set
Top 16%
12.4%
3
Biochemical and Biophysical Research Communications
78 papers in training set
Top 0.1%
6.9%
4
Cell Proliferation
12 papers in training set
Top 0.1%
6.4%
5
Stem Cell Research & Therapy
30 papers in training set
Top 0.1%
6.4%
6
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 1%
4.2%
50% of probability mass above
7
Scientific Reports
3102 papers in training set
Top 36%
3.6%
8
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 0.8%
2.9%
9
Annals of Translational Medicine
17 papers in training set
Top 0.4%
2.8%
10
Acta Biochimica et Biophysica Sinica
19 papers in training set
Top 0.2%
2.1%
11
Journal of the American Heart Association
119 papers in training set
Top 2%
2.1%
12
Protein & Cell
25 papers in training set
Top 1%
1.9%
13
eLife
5422 papers in training set
Top 41%
1.7%
14
Journal of Molecular Cell Biology
21 papers in training set
Top 0.2%
1.7%
15
Cell Discovery
54 papers in training set
Top 3%
1.5%
16
Stem Cells Translational Medicine
11 papers in training set
Top 0.1%
1.5%
17
International Journal of Molecular Sciences
453 papers in training set
Top 9%
1.5%
18
Journal of Molecular and Cellular Cardiology
39 papers in training set
Top 0.6%
1.3%
19
Frontiers in Medicine
113 papers in training set
Top 6%
0.9%
20
Advanced Science
249 papers in training set
Top 16%
0.9%
21
Cells
232 papers in training set
Top 5%
0.9%
22
Biochemistry and Biophysics Reports
28 papers in training set
Top 1%
0.8%
23
npj Regenerative Medicine
21 papers in training set
Top 0.3%
0.8%
24
Stem Cell Reports
118 papers in training set
Top 0.9%
0.8%
25
International Immunopharmacology
15 papers in training set
Top 0.5%
0.8%
26
Biomedicines
66 papers in training set
Top 3%
0.8%
27
FASEB BioAdvances
15 papers in training set
Top 0.4%
0.6%
28
Stem Cells
28 papers in training set
Top 0.6%
0.6%
29
Journal of Personalized Medicine
28 papers in training set
Top 2%
0.6%
30
Developmental Biology
134 papers in training set
Top 3%
0.5%